Argatroban as an Alternative Anticoagulant in Impella Supported Patients

Volume: 40, Issue: 4, Pages: S389 - S389
Published: Apr 1, 2021
Abstract
PurposeTo investigate the safety and efficacy of argatroban in preventing thrombotic complications in patients with suspected heparin-induced thrombocytopenia (HIT) treated with axillary flow left ventricular assist device (Impella).MethodsWe performed a retrospective observational case-series of patients who were supported on Impella and anticoagulated with argatroban due to suspected HIT. The electronic medical record was reviewed for safety...
Paper Details
Title
Argatroban as an Alternative Anticoagulant in Impella Supported Patients
Published Date
Apr 1, 2021
Volume
40
Issue
4
Pages
S389 - S389
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.